G. M. Reaven

2.5k total citations
43 papers, 2.0k citations indexed

About

G. M. Reaven is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, G. M. Reaven has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Physiology and 15 papers in Molecular Biology. Recurrent topics in G. M. Reaven's work include Metabolism, Diabetes, and Cancer (12 papers), Adipose Tissue and Metabolism (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). G. M. Reaven is often cited by papers focused on Metabolism, Diabetes, and Cancer (12 papers), Adipose Tissue and Metabolism (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). G. M. Reaven collaborates with scholars based in United States, Australia and Italy. G. M. Reaven's co-authors include Eve Reaven, Phyllis A Crapo, W. L. Haskell, C. E. Mondon, Charles R. Sims, C.B. Hollenbeck, Fahim Abbasi, G Gold, Tracey McLaughlin and Ann M. Coulston and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and American Journal of Clinical Nutrition.

In The Last Decade

G. M. Reaven

42 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. M. Reaven United States 26 865 854 451 368 357 43 2.0k
C. Bogardus United States 18 611 0.7× 1.1k 1.3× 552 1.2× 389 1.1× 267 0.7× 29 2.1k
Aldo V. Greco Italy 28 448 0.5× 866 1.0× 658 1.5× 470 1.3× 564 1.6× 60 2.3k
Joy C. Bunt United States 24 643 0.7× 1.0k 1.2× 250 0.6× 484 1.3× 356 1.0× 42 2.4k
Hans Wahrenberg Sweden 30 911 1.1× 1.5k 1.8× 444 1.0× 589 1.6× 576 1.6× 59 3.0k
A. Franssila-Kallunki Finland 21 720 0.8× 657 0.8× 556 1.2× 187 0.5× 381 1.1× 30 1.7k
S. R. Bloom United Kingdom 25 566 0.7× 443 0.5× 473 1.0× 211 0.6× 522 1.5× 78 2.0k
Edmond Balasse Belgium 25 758 0.9× 1.4k 1.6× 344 0.8× 194 0.5× 275 0.8× 59 2.0k
Toshihide Yoshida Japan 28 299 0.3× 1.2k 1.4× 445 1.0× 338 0.9× 214 0.6× 101 2.0k
Ayman M. Arafat Germany 25 1.1k 1.2× 669 0.8× 502 1.1× 290 0.8× 281 0.8× 52 2.2k
B. Nyholm Denmark 23 759 0.9× 566 0.7× 549 1.2× 231 0.6× 570 1.6× 38 1.7k

Countries citing papers authored by G. M. Reaven

Since Specialization
Citations

This map shows the geographic impact of G. M. Reaven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. M. Reaven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. M. Reaven more than expected).

Fields of papers citing papers by G. M. Reaven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. M. Reaven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. M. Reaven. The network helps show where G. M. Reaven may publish in the future.

Co-authorship network of co-authors of G. M. Reaven

This figure shows the co-authorship network connecting the top 25 collaborators of G. M. Reaven. A scholar is included among the top collaborators of G. M. Reaven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. M. Reaven. G. M. Reaven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simmons, Rebecca K., K. G. M. M. Alberti, E. A. M. Gale, et al.. (2010). The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Obesity and metabolism. 7(3). 49–51. 28 indexed citations
2.
Yee, Gail, Fahim Abbasi, Cindy Lamendola, et al.. (2009). Pioglitazone Increases the Proportion of Small Cells in Human Abdominal Subcutaneous Adipose Tissue. Obesity. 18(5). 926–931. 73 indexed citations
3.
McLaughlin, Tracey, Fahim Abbasi, Hee Sun Kim, et al.. (2001). Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism. 50(7). 795–800. 72 indexed citations
4.
McLaughlin, Tracey & G. M. Reaven. (2000). Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease.. PubMed. 55(6). 28–32, 35. 14 indexed citations
5.
6.
Carantoni, M., Fahim Abbasi, Salman Azhar, Patricia Schaaf, & G. M. Reaven. (1999). Can Changes in Plasma Insulin Concentration Explain the Variability in Leptin Response to Weight Loss in Obese Women with Normal Glucose Tolerance?1. The Journal of Clinical Endocrinology & Metabolism. 84(3). 869–872. 25 indexed citations
7.
Abbasi, Fahim, Cindy Lamendola, Tracey McLaughlin, et al.. (1999). Mononuclear Cell Adherence to Cultured Endothelium Is Enhanced by Hypertension and Insulin Resistance in Healthy Nondiabetic Volunteers. Circulation. 100(9). 940–943. 37 indexed citations
8.
Reaven, G. M.. (1999). Syndrome X: Past, present, & future. Atherosclerosis. 144. 12–12. 2 indexed citations
9.
Reaven, G. M., et al.. (1994). Plasma lactate concentration in obesity and type 2 diabetes.. PubMed. 19(4). 348–54. 70 indexed citations
10.
Swislocki, Arthur, Robert E. Vestal, G. M. Reaven, & Brian B. Hoffman. (1993). Acute Metabolic Effects of Clonidine and Adenosine in Man. Hormone and Metabolic Research. 25(2). 90–95. 11 indexed citations
11.
Hollenbeck, C.B., et al.. (1991). Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.. PubMed. 17(5). 483–9. 46 indexed citations
12.
Reaven, G. M. & Helen Ho. (1991). Low-dose streptozotocin-induced diabetes in the spontaneously hypertensive rat. Metabolism. 40(4). 335–337. 26 indexed citations
13.
Reaven, G. M., Helen Ho, & Brian B. Hoffman. (1990). Effects of a Fructose-Enriched Diet on Plasma Insulin and Triglyceride Concentration in SHR and WKY Rats. Hormone and Metabolic Research. 22(7). 363–365. 29 indexed citations
14.
Reaven, G. M., et al.. (1989). Effect of Age on Glucose Tolerance and Glucose Uptake in Healthy Individuals. Journal of the American Geriatrics Society. 37(8). 735–740. 55 indexed citations
15.
Reaven, G. M., Helen Chang, & Brian B. Hoffman. (1989). Impaired Insulin-Mediated Inhibition of Lipolysis and Glucose Transport with Aging. Hormone and Metabolic Research. 21(4). 168–171. 8 indexed citations
16.
Reaven, G. M., et al.. (1988). Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes/Metabolism Reviews. 4(7). 639–652. 129 indexed citations
17.
Rabkin, Ralph, G. M. Reaven, & C. E. Mondon. (1986). Insulin metabolism by liver, muscle, and kidneys from spontaneously diabetic rats. American Journal of Physiology-Endocrinology and Metabolism. 250(5). E530–E537. 10 indexed citations
18.
Mondon, C. E., C. B. Dolkas, Charles R. Sims, & G. M. Reaven. (1985). Spontaneous running activity in male rats: effect of age. Journal of Applied Physiology. 58(5). 1553–1557. 72 indexed citations
19.
Reaven, Eve & G. M. Reaven. (1981). Structure and function changes in the endocrine pancreas of aging rats with reference to the modulating effects of exercise and caloric restriction.. Journal of Clinical Investigation. 68(1). 75–84. 73 indexed citations
20.
Reaven, Eve, G Gold, & G. M. Reaven. (1979). Effect of age on glucose-stimulated insulin release by the beta-cell of the rat.. Journal of Clinical Investigation. 64(2). 591–599. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Bogardus Breakdown of academic impact, for papers by Aldo V. Greco Breakdown of academic impact, for papers by Joy C. Bunt Breakdown of academic impact, for papers by Hans Wahrenberg Breakdown of academic impact, for papers by A. Franssila-Kallunki Breakdown of academic impact, for papers by S. R. Bloom Breakdown of academic impact, for papers by Edmond Balasse Breakdown of academic impact, for papers by Toshihide Yoshida Breakdown of academic impact, for papers by Ayman M. Arafat Breakdown of academic impact, for papers by B. Nyholm
Rankless by CCL
2026